Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Conestoga SMid Cap Composite. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD-8.65%
YTD-12.23%
Annualized+9.03%
Positioning StanceCONSTRUCTIVE
Market CapSMID Cap
GeographyUS
Digest Analysis
Quick Take
"Positioned defensively in high-quality mid-cycle compounders across infrastructure, healthcare, and software while initiating new longs in $ALGM, $MTSI, and $STRL amid rising rates and valuation compression."
Executive Summary
The Conestoga SMid Cap Composite returned -8.65% net of fees in the third quarter of 2026, outperforming the Russell 2500 Growth Index benchmark return of -10.35%. Year-to-date, the strategy has returned -12.23% net of fees compared to +7.28% for the benchmark. While high-beta, momentum-driven market leadership weakened considerably, higher-quality company attributes—such as robust margins and lower beta—helped protect capital on a relative basis. Negative sector performance was heavily concentrated in Industrials, which slid 16% across the benchmark, though positive stock selection and overweight positioning in Software and Health Care suppliers partially cushioned broad equity declines. Cash stood at 3.1% of assets at quarter-end.
Macroeconomic crosscurrents dominated the quarter as persistent inflation prints, resilient labor market conditions, and crude oil spiking above $101 per barrel due to Middle East tensions pushed Treasury yields across the 10- and 30-year curves to 25-year highs. The Federal Reserve raised the federal funds rate by 25 basis points in September to a 3.75%-4.00% target range. Although premium-multiple growth stocks faced valuation compression, Conestoga maintains that the market's transition to a mid-cycle regime will increasingly reward disciplined compounders exhibiting durable business models, conservative capital structures, and pricing power.
Portfolio turnover during the quarter included additions on twelve occasions and trims on thirteen occasions. The manager initiated new positions in Allegro Microsystems, MACOM Technology Solutions, Sterling Infrastructure, Standex International, SEI Corp., and Cognex Corp., targeting secular beneficiaries in electrification, advanced defense electronics, and data center infrastructure. Conversely, the strategy exited Bio-Techne following its announced acquisition by Merck KGaA, alongside divestments in Workiva, Bright Horizons Family Solutions, and EVI Industries to redeploy capital into higher-conviction franchises.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
72%
CautiousHigh
High Conviction (72%)
Conestoga demonstrates disciplined conviction through top-ten concentration representing 36.15% of the composite, while executing high-conviction thematic rotations into newly initiated long positions like ALGM, MTSI, STRL, and CGNX. However, the overall strategy remains diversified across numerous SMid cap names and maintains disciplined, incremental capacity trimming rules.
Growth Outlook
58%
BearishBullish
Neutral (58%)
The manager remains optimistic regarding the long-term outlook for quality growth compounders, citing historically attractive small- and mid-cap valuations relative to large caps. Nonetheless, this optimism is tempered by near-term caution regarding stubborn inflation, elevated benchmark bond yields, and ongoing valuation compression among high-P/E growth equities.
Risk Appetite
62%
DefensiveAggressive
Balanced (62%)
Capital is allocated primarily to equities with modest cash reserves of 3.1%, maintaining active growth positioning while selectively pruning software names exposed to AI disruption risk. The team deliberately emphasizes lower-beta, high-ROIC compounders over high-beta speculative momentum names.
Capital Deployment
65%
De-riskingDeploying
Net Neutral (65%)
Portfolio actions reflected balanced but active deployment, establishing six new long positions and adding to twelve existing holdings while maintaining modest cash reserves of 3.1% to capitalize on pullbacks.
Forward Guidance
65%
CautiousExpansionary
Expansionary (65%)
Management actively seized third-quarter market volatility to initiate six new equity holdings, adding to positions on twelve occasions while reallocating capital away from acquisition-dependent or disrupted business models. They express a clear bias toward deploying into high-quality companies at attractive valuations.
Language Signal
60%
BearishBullish
Balanced (60%)
Letter commentary combines constructive descriptions of record backlogs, expanding margins, and secular demand drivers alongside recurring acknowledgments of macro headwinds, inflation fears, and disappointing quarter-to-quarter earnings volatility in certain holdings.
Perceived Risk
68%
Low RiskElevated
Elevated Risk (68%)
The manager articulates acute awareness of macroeconomic and market risks, detailing 25-year highs in Treasury yields, the Fed's hawkish policy path, oil price spikes from geopolitical conflict in the Strait of Hormuz, and valuation multiple compression across high-P/E growth stocks.
Opportunity Density
68%
ScarceAbundant
Abundant (68%)
The manager identifies an attractive and fertile opportunity set within SMid cap equities, highlighting multiple niche opportunities in data center infrastructure, electrification, bioprocessing, and compliance software following broad market pullbacks.
Time Horizon
78%
Short-TermLong-Term
Decade+ (78%)
Investment rationale is explicitly oriented around multi-year business fundamentals and full market cycles rather than short-term quarterly noise. The manager repeatedly highlights multi-year order backlogs, long-term qualification cycles, and durable compounding potential.